PROLANZA olanzapine 7.5mg tablet blister pack

Active ingredient:

olanzapine, Quantity: 7.5 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Olanzapine

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: magnesium stearate; microcrystalline cellulose; hyprolose; purified talc; crospovidone; lactose monohydrate; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin

Administration route:

Oral

Units in package:

7, 50, 14, 10, 21, 30, 20, 40, 60, 28

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

For the treatment of schizophrenia and related psychoses. ,Alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Product summary:

Visual Identification: White, round, biconvex film coated tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

2011-08-11